Page last updated: 2024-11-06

thiazopyr

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Thiazopyr is a synthetic herbicide belonging to the pyrazole group. Its primary mode of action is through inhibiting the synthesis of protoporphyrin IX, a crucial molecule in chlorophyll production. This disruption disrupts photosynthesis and leads to plant death. Thiazopyr is effective in controlling a wide range of weeds, particularly grasses, in crops such as soybeans, peanuts, and cotton. It is commonly used as a pre-emergence herbicide, applied before the weeds germinate. Research on thiazopyr focuses on understanding its environmental fate, its impact on non-target organisms, and developing more efficient and sustainable applications. Notably, thiazopyr's selectivity for specific weeds and its relatively low persistence in soil make it a valuable tool for weed management. However, continued research is essential to ensure its responsible and safe use.'

thiazopyr: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID91776
CHEMBL ID1886222
CHEBI ID166573
SCHEMBL ID53467
MeSH IDM0242220

Synonyms (36)

Synonym
CHEBI:166573
methyl 2-(diluoromethyl)-5-(4,5-dihydro-1,3-thiazol-2-yl)-4-(2-methylpropyl)-6-(triluoromethyl)pyridine-3-carboxylate
mon 13200
thiazophyr
thiazopyr [iso]
mon 13211
3-pyridinecarboxylic acid, 2-(difluoromethyl)-5-(4,5-dihydro-2-thiazolyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-, methyl ester
visor
mandate
hsdb 7015
methyl 2-(difluoromethyl)-5-(4,5-dihydro-2-thiazolyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3-pyridinecarboxylate
NCGC00163867-01
thiazopyr
methyl 2-(difluoromethyl)-5-(4,5-dihydro-1,3-thiazol-2-yl)-4-isobutyl-6-(trifluoromethyl)nicotinate
117718-60-2
NCGC00163867-02
methyl 2-(difluoromethyl)-5-(4,5-dihydro-1,3-thiazol-2-yl)-4-(2-methylpropyl)-6-(trifluoromethyl)pyridine-3-carboxylate
NCGC00163867-03
tox21_300822
cas-117718-60-2
dtxsid1032488 ,
NCGC00254726-01
dtxcid9012488
147172-37-0
aeq9r142xi ,
unii-aeq9r142xi
FT-0631089
AKOS015890794
SCHEMBL53467
thiazopyr [mi]
thiazopyr [hsdb]
methyl 2-difluoromethyl-5-(4,5-dihydro-1,3-thiazol-2-yl)-4-isobutyl-6-trifluoromethylnicotinate
CHEMBL1886222
methyl 2-(difluoromethyl)-5-(4,5-dihydrothiazol-2-yl)-4-isobutyl-6-(trifluoromethyl)nicotinate
Q22808964
methyl 2-(difluoromethyl)-5-(4,5-dihydro-1,3-thiazol-2-yl)-4-(2-methyl propyl)-6-(trifluoromethyl)py

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
aromatic carboxylic acidAny carboxylic acid in which the carboxy group is directly bonded to an aromatic ring.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
pregnane X receptorRattus norvegicus (Norway rat)Potency31.62280.025127.9203501.1870AID651751
RAR-related orphan receptor gammaMus musculus (house mouse)Potency45.00290.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency24.33650.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency49.31270.000221.22318,912.5098AID1259243; AID743042; AID743054
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency34.37620.001022.650876.6163AID1224839
progesterone receptorHomo sapiens (human)Potency54.48270.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency44.66840.000817.505159.3239AID588544
pregnane X nuclear receptorHomo sapiens (human)Potency0.88480.005428.02631,258.9301AID1346982; AID720659
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.58960.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.85 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]